Published on
July 17, 2024
- 09:00 GMT
X-ZELL outperforms traditional immunostaining in German landmark study
LEIPZIG, GERMANY, July 17, 2024 /EINPresswire.com/ -- New research from Germany has shown that X-ZELL technology could dramatically reduce the number of inconclusive cancer diagnoses from minimally invasive sample material. During a lecture given at …
Distribution channels:
Business & Economy, Companies
...
